Anthrax Toxin Receptor (Intermediate Domain) Blocking Peptide [A312] : Leinco Technologies, excellence in early discovery research

0 $0.00

Product Datasheet

www.leinco.com

excellence in early discovery research

Anthrax Toxin Receptor (Intermediate Domain) Blocking Peptide

(ATR, TEM8, Tumor Endothelial Marker 8)

Blocking Peptide

Share |

Size

50 µg ( $115.00 )

Add to Cart:

Prod. No.:	A312
Conc.:	0.2 mg/ml
Pkg. Size:	50 µg
Storage:	-20°C Detailed storage instructions below.

Description

Background:

ATR peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Amino Acid Location

13 amino acids near the center of human ATR.

Formulation

This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.

Storage and Stability

Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Reported Applications

Indirect ELISA, N

Neutralization: The peptide may be used to neutralize the binding activity of Anti-Human Anthrax Toxin Receptor (Intermediate Domain) (ATR) (Leinco Prod. No.: A288) by incubation of an equal volume of the peptide and antibody for 30 minutes at 37°C for Western blotting experiments.

Each investigator should determine their own optimal working dilution for specific applications.

Country of Origin

USA

References

1. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001;412(6842):95-9.

2. Parrish J, Li L, Klotz K, Ledwich D, Wang X, Xue D. Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature. 2001;412(6842):90-4

3. Hengartner MO. Apoptosis. DNA destroyers. Nature. 2001;412(6842):27, 29.

4. Widlak P, Li LY, Wang X, Garrard WT. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem. 2001;276(51):48404-9.